The objective of this study was to present the engineering and clinical aspects of a new balloon expandable coronary
stent. A new tubular,
serpentine design
stainless steel balloon-expandable
stent, the beStent, was designed based on clinical requirements for
stents and has been clinically evaluated in multiple sites. The
stent is featured by terminal
gold markers and rotational junctions that assure no shortening upon expansion and lead to orthogonal locking, maximizing radial strength. In terms of methods and results, the
stent was clinically evaluated in the framework of a pilot evaluation in a variety of lesion types. The short- and long-term results evaluated during the course of the beStent multicenter pilot evaluation and in our single center study are reported. A variety of patients were included, including patients with long complex lesions, restenosis lesions, and total occlusions. Short-term clinical success with stenting was achieved in more than 97% of the cases. Subacute
thrombosis was low in 1% of the cases. Clinical restenosis rates were acceptable with an overall 85% 6 month event free survival. In conclusion, the mechanical features of the
stent providing its flexibility, scaffolding properties, radial strength, and absence of shortening were tested in a clinical study, showing that it is safe and effective for treating simple as well as long and complex lesions associated with
coronary disease with a relatively low rate of complications.